|188.58||-3.08||-1.61%||Vol 1.57M||1Y Perf 81.98%|
|Apr 13th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||174.46||Analyst Rating||Strong Buy 1.40|
|Potential %||-7.49||Finscreener Ranking||★ 40.75|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||+ 37.37|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★+ 42.53|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||☆ 25.80|
|Market Cap||63.54B||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||94.72||Earnings Date||22nd Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||22nd Apr 2021|
|Estimated EPS Next Report||3.28|
|EPS Growth Next 5 Years %||11.70|
|Avg. Weekly Volume||1.24M|
|Avg. Monthly Volume||1.46M|
|Avg. Quarterly Volume||1.57M|
HCA Healthcare Inc. (NYSE: HCA) stock closed at 188.58 per share at the end of the most recent trading day (a -1.61% change compared to the prior day closing price) with a volume of 1.59M shares and market capitalization of 63.54B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 275000 people. HCA Healthcare Inc. CEO is Samuel N. Hazen.
The one-year performance of HCA Healthcare Inc. stock is 81.98%, while year-to-date (YTD) performance is 14.67%. HCA stock has a five-year performance of 133.62%. Its 52-week range is between 91.21 and 194.01, which gives HCA stock a 52-week price range ratio of 94.72%
HCA Healthcare Inc. currently has a PE ratio of 14.90, a price-to-book (PB) ratio of 110.77, a price-to-sale (PS) ratio of 1.67, a price to cashflow ratio of 7.00, a PEG ratio of 2.32, a ROA of 7.78%, a ROC of -% and a ROE of -302.11%. The company’s profit margin is 9.69%, its EBITDA margin is 18.90%, and its revenue ttm is $38.67 Billion , which makes it $114.78 revenue per share.
Of the last four earnings reports from HCA Healthcare Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $3.28 for the next earnings report. HCA Healthcare Inc.’s next earnings report date is 22nd Apr 2021.
The consensus rating of Wall Street analysts for HCA Healthcare Inc. is Strong Buy (1.4), with a target price of $174.46, which is -7.49% compared to the current price. The earnings rating for HCA Healthcare Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
HCA Healthcare Inc. has a dividend yield of 1.00% with a dividend per share of $1.92 and a payout ratio of 8.00%.
HCA Healthcare Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.78, ATR14 : 5.72, CCI20 : 65.84, Chaikin Money Flow : -0.22, MACD : 4.42, Money Flow Index : 55.47, ROC : 0.66, RSI : 57.16, STOCH (14,3) : 52.96, STOCH RSI : 0.19, UO : 45.83, Williams %R : -47.04), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of HCA Healthcare Inc. in the last 12-months were: A. Bruce Moore (Option Excercise at a value of $1 147 500), A. Bruce Moore (Sold 25 000 shares of value $3 805 265 ), Charles J. Hall (Option Excercise at a value of $6 971 058), Charles J. Hall (Sold 21 536 shares of value $3 099 961 ), Christopher F. Wyatt (Option Excercise at a value of $551 680), Christopher F. Wyatt (Sold 3 200 shares of value $566 580 ), Deborah M. Reiner (Option Excercise at a value of $756 847), Deborah M. Reiner (Sold 6 344 shares of value $966 817 ), J. William B. Morrow (Sold 9 218 shares of value $1 396 132 ), Jane D. Englebright (Sold 14 486 shares of value $2 210 613 ), Jennifer Berres (Option Excercise at a value of $813 110), Jennifer Berres (Sold 10 164 shares of value $1 661 384 ), Jon M. Foster (Option Excercise at a value of $3 451 792), Jon M. Foster (Sold 35 823 shares of value $4 526 794 ), Jonathan B. Perlin (Option Excercise at a value of $6 850 723), Jonathan B. Perlin (Sold 22 533 shares of value $3 356 869 ), Kathleen M. Whalen (Option Excercise at a value of $67 158), Kathleen M. Whalen (Sold 280 shares of value $49 591 ), Kathryn A. Torres (Option Excercise at a value of $2 012 459), Kathryn A. Torres (Sold 5 066 shares of value $885 862 ), Martin P. Paslick (Option Excercise at a value of $1 464 284), Martin P. Paslick (Sold 13 733 shares of value $1 963 602 ), Michael S. Cuffe (Option Excercise at a value of $2 819 014), Michael S. Cuffe (Sold 21 292 shares of value $3 713 848 ), P. Martin Paslick (Option Excercise at a value of $1 464 284), P. Martin Paslick (Sold 4 089 shares of value $619 778 ), Robert A. Waterman (Option Excercise at a value of $9 237 352), Robert A. Waterman (Sold 136 789 shares of value $24 216 675 ), Samuel N. Hazen (Option Excercise at a value of $15 135 876), Samuel N. Hazen (Sold 121 875 shares of value $16 527 839 ), Sandra L. Morgan (Sold 5 030 shares of value $642 564 ), Wayne Joseph Riley (Sold 4 950 shares of value $876 464 ), William B. Rutherford (Option Excercise at a value of $2 007 696), William B. Rutherford (Sold 36 250 shares of value $5 050 676 ), William J Morrow (Option Excercise at a value of $971 877), William J Morrow (Sold 13 058 shares of value $1 911 624 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.